Enabling personalized cancer medicine through analysis of gene-expression patterns

Laura J. van 't Veer and René Bernards
Additional contact information
Laura J. van 't Veer: Agendia BV, Louwesweg 6
René Bernards: Agendia BV, Louwesweg 6

Nature, 2008, vol. 452, issue 7187, 564-570

Abstract: Abstract Therapies for patients with cancer have changed gradually over the past decade, moving away from the administration of broadly acting cytotoxic drugs towards the use of more-specific therapies that are targeted to each tumour. To facilitate this shift, tests need to be developed to identify those individuals who require therapy and those who are most likely to benefit from certain therapies. In particular, tests that predict the clinical outcome for patients on the basis of the genes expressed by their tumours are likely to increasingly affect patient management, heralding a new era of personalized medicine.

Date: 2008
References: Add references at CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
https://www.nature.com/articles/nature06915 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:452:y:2008:i:7187:d:10.1038_nature06915

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature06915

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().